HARLEEN KAURA: Open Payments
NPI 1174270706 · BELTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,998 in 144 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $601 · 2025 $2,998
Food & beverage: $2,791Education: $207
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $473 |
| Merck Sharp & Dohme LLC | 15 | $283 |
| Novartis Pharmaceuticals Corporation | 12 | $245 |
| PFIZER INC. | 13 | $225 |
| GlaxoSmithKline, LLC. | 11 | $219 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| ABBVIE INC. | 9 | $146 |
| Incyte Corporation | 6 | $111 |
| Genentech USA, Inc. | 4 | $94 |
| SEAGEN INC. | 1 | $93 |
Products named: KEYTRUDA, DARZALEX, RYBREVANT, KISQALI, OJJAARA, ERLEADA, XYNTHA, Orserdu.
Industry payments across MO — which companies pay providers there.
